MMB-CHMICA: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:MMB-CHMICA}} | |||
== | == Overview == | ||
MMB-CHMICA is | '''MMB-CHMICA''' is a synthetic cannabinoid that has been used in scientific research and recreational drug use. It is a potent agonist of the [[cannabinoid receptor]]s, primarily the [[CB1 receptor]], and is known for its psychoactive effects. MMB-CHMICA is part of a class of compounds known as [[designer drugs]], which are often created to mimic the effects of [[cannabis]] while avoiding legal restrictions. | ||
== | == Chemical Structure == | ||
MMB-CHMICA | [[File:MMB-CHMICA.svg|thumb|right|Chemical structure of MMB-CHMICA]] | ||
MMB-CHMICA is chemically classified as an indole-based synthetic cannabinoid. Its structure includes a methyl ester group, which is a common feature in many synthetic cannabinoids. The compound is known for its high affinity and selectivity for the CB1 receptor, which contributes to its potent psychoactive effects. | |||
== | == Pharmacology == | ||
The | MMB-CHMICA acts as a full agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects of cannabinoids. The activation of this receptor by MMB-CHMICA leads to a range of effects, including altered perception, mood changes, and cognitive impairment. The compound's high potency and efficacy at the CB1 receptor make it a subject of interest in both pharmacological research and forensic analysis. | ||
==Legal Status== | == Legal Status == | ||
MMB-CHMICA | Due to its potential for abuse and lack of medical use, MMB-CHMICA has been classified as a controlled substance in many jurisdictions. It is often included in legislation targeting [[new psychoactive substances]] (NPS) and synthetic cannabinoids. The legal status of MMB-CHMICA can vary significantly between countries, with some having specific bans on the compound and others including it under broader synthetic cannabinoid regulations. | ||
== | == Health Effects == | ||
The use of MMB-CHMICA has been associated with a range of adverse health effects. These can include [[tachycardia]], [[hypertension]], [[nausea]], [[vomiting]], and [[anxiety]]. In severe cases, use of the compound can lead to [[psychosis]], [[seizures]], and even [[death]]. The variability in the potency and purity of synthetic cannabinoids like MMB-CHMICA further complicates the risk profile for users. | |||
== Related Pages == | |||
* [[Synthetic cannabinoids]] | * [[Synthetic cannabinoids]] | ||
* [[Cannabinoid receptor]] | * [[Cannabinoid receptor]] | ||
* [[Designer drugs]] | |||
* [[New psychoactive substances]] | |||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
[[Category:Designer drugs]] | [[Category:Designer drugs]] | ||
Latest revision as of 04:04, 13 February 2025
Overview[edit]
MMB-CHMICA is a synthetic cannabinoid that has been used in scientific research and recreational drug use. It is a potent agonist of the cannabinoid receptors, primarily the CB1 receptor, and is known for its psychoactive effects. MMB-CHMICA is part of a class of compounds known as designer drugs, which are often created to mimic the effects of cannabis while avoiding legal restrictions.
Chemical Structure[edit]
MMB-CHMICA is chemically classified as an indole-based synthetic cannabinoid. Its structure includes a methyl ester group, which is a common feature in many synthetic cannabinoids. The compound is known for its high affinity and selectivity for the CB1 receptor, which contributes to its potent psychoactive effects.
Pharmacology[edit]
MMB-CHMICA acts as a full agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects of cannabinoids. The activation of this receptor by MMB-CHMICA leads to a range of effects, including altered perception, mood changes, and cognitive impairment. The compound's high potency and efficacy at the CB1 receptor make it a subject of interest in both pharmacological research and forensic analysis.
Legal Status[edit]
Due to its potential for abuse and lack of medical use, MMB-CHMICA has been classified as a controlled substance in many jurisdictions. It is often included in legislation targeting new psychoactive substances (NPS) and synthetic cannabinoids. The legal status of MMB-CHMICA can vary significantly between countries, with some having specific bans on the compound and others including it under broader synthetic cannabinoid regulations.
Health Effects[edit]
The use of MMB-CHMICA has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and anxiety. In severe cases, use of the compound can lead to psychosis, seizures, and even death. The variability in the potency and purity of synthetic cannabinoids like MMB-CHMICA further complicates the risk profile for users.
